Showing results (841-850 of 1,020) with videos related to
Sort By:
Pageof 102
Cancer Research Communications|October 26, 2023
Enitociclib, a Selective CDK9 Inhibitor, Induces Complete Regression of MYC+ Lymphoma by Downregulation of RNA Polymerase II Mediated TranscriptionMelanie M Frigault, Arushi Mithal, Harvey Wong, et al.Cancer Research Communications|September 29, 2023
Accelerating Cancer Histopathology Workflows with Chemical Imaging and Machine LearningKianoush Falahkheirkhah, Sudipta S Mukherjee, Sounak Gupta, et al.Cancer Research Communications|September 29, 2023
AKR1C3 Converts Castrate and Post-Abiraterone DHEA-S into Testosterone to Stimulate Growth of Prostate Cancer Cells via 5-Androstene-3β,17β-DiolAndrea J Detlefsen, Clementina A Mesaros, Ling Duan, et al.Cancer Research Communications|September 20, 2023
The Inherited KRAS-variant as a Biomarker of Cetuximab Response in NSCLCJoanne B Weidhaas, Chen Hu, Ritsuko Komaki, et al.Cancer Research Communications|September 21, 2023
Piperacetazine Directly Binds to the PAX3::FOXO1 Fusion Protein and Inhibits Its Transcriptional ActivityKay Nakazawa, Taryn Shaw, Young K Song, et al.Cancer Research Communications|September 21, 2023
Chromatin Accessibility Landscape of Human Triple-negative Breast Cancer Cell Lines Reveals Variation by Patient Donor AncestryAlexandra R Harris, Gatikrushna Panigrahi, Huaitian Liu, et al.Cancer Research Communications|September 18, 2023
HER2-Selective and Reversible Tyrosine Kinase Inhibitor Tucatinib Potentiates the Activity of T-DM1 in Preclinical Models of HER2-positive Breast CancerDevra Olson, Janelle Taylor, Kelsi Willis, et al.Cancer Research Communications|July 12, 2023
Phase Ib/II Study of a Liposomal Formulation of Eribulin (E7389-LF) plus Nivolumab in Patients with Advanced Solid Tumors: Results from Phase IbHanae Ida, Toshio Shimizu, Makoto Nishino, et al.Cancer Research Communications|July 7, 2023
Evaluating Work Impairment as a Source of Financial Toxicity in Cancer Healthcare and Negative Impacts on Health StatusDinesh Pal Mudaranthakam, Nicole Nollen, Jo Wick, et al.Cancer Research Communications|July 14, 2022
Real-World Studies Link Nonsteroidal Anti-inflammatory Drug Use to Improved Overall Lung Cancer SurvivalJason Roszik, J Jack Lee, Yi-Hung Wu, et al.Pageof 102